Recorded Presentations from the NCCN 19th Annual Conference: Hematologic Malignancies
Overview:
The NCCN Annual Conference attracts more than 1,500 registrants from across the United States and the globe including oncologists (in both community and academic settings), oncology fellows, nurses, pharmacists, and other health care professionals involved in the care of patients with cancer. Respected opinion leaders present the latest cancer therapies and provide updates on selected NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), the data upon which the NCCN Guidelines are based, and quality initiatives in oncology. Topics change annually but focus on the major cancers and supportive care areas. The NCCN Annual Conference also includes case study discussion forums with experts from NCCN Member Institutions and roundtable discussions featuring the foremost professionals from the academic, patient advocacy, government, payer, industry, and business realms of cancer care.
Intended Audience:
These activities are designed to meet the educational needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
Accreditation Information:
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before the individual educational activity for more details.
Fee Information:
There is no fee for these activities.
Supporters:
Supported by educational grants from Bristol-Myers Squibb; Novartis Oncology; Spectrum Pharmaceuticals, Inc.; and Takeda Oncology. Supported by a grant from Onyx Pharmaceuticals.